{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:42:05Z","timestamp":1780666925808,"version":"3.54.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["#2002193"],"award-info":[{"award-number":["#2002193"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#2025894"],"award-info":[{"award-number":["#2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024339","name":"Monash Addiction Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine the predictors of persistent opioid use (\u201cpersistence\u201d) in people initiating opioids for non-cancer pain in Australian primary care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A retrospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Australian primary care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>People prescribed opioid analgesics between 2018 and 2022, identified through the Population Level Analysis and Reporting (POLAR) database.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Persistence was defined as receiving opioid prescriptions for at least 90\u2009days with a gap of less than 60\u2009days between subsequent prescriptions. Multivariable logistic regression was used to examine the predictors of persistent opioid use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The sample consisted of 343\u200a023 people initiating opioids for non-cancer pain; of these, 16\u200a527 (4.8%) developed persistent opioid use. Predictors of persistence included older age (\u226575 vs 15\u201344\u2009years: adjusted odds ratio: 1.67, 95% CI: 1.58\u20131.78); concessional beneficiary status (1.78, 1.71\u20131.86); diagnosis of substance use disorder (1.44, 1.22\u20131.71) or chronic pain (2.05, 1.85\u20132.27); initiation of opioid therapy with buprenorphine (1.95, 1.73\u20132.20) or long-acting opioids (2.07, 1.90\u20132.25); provision of higher quantity of opioids prescribed at initiation (total oral morphine equivalents of \u2265750\u00a0mg vs &amp;lt;100\u00a0mg: 7.75, 6.89\u20138.72); provision of repeat\/refill opioid prescriptions at initiation (2.94, 2.77\u20133.12); and prescription of gabapentinoids (1.59, 1.50\u20131.68), benzodiazepines (1.43, 1.38\u20131.50), and z-drugs (eg, zopiclone, zolpidem; 1.61, 1.46\u20131.78).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings add to the limited evidence of individual-level factors associated with persistent opioid use. Further research is needed to understand the clinical outcomes of persistent opioid use in people with these risk factors to support the safe and effective prescribing of opioids.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnae071","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:20:52Z","timestamp":1723004452000},"page":"748-757","source":"Crossref","is-referenced-by-count":7,"title":["Predictors of persistent opioid use in Australian primary care: a retrospective cohort study, 2018\u20132022"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6458-1279","authenticated-orcid":false,"given":"Monica","family":"Jung","sequence":"first","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School, Monash University , Melbourne, Victoria 3199,","place":["Australia"]},{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Melbourne, Victoria 3052,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xia","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School, Monash University , Melbourne, Victoria 3199,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Ilom\u00e4ki","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Melbourne, Victoria 3052,","place":["Australia"]},{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University , Melbourne, Victoria 3004,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Pearce","sequence":"additional","affiliation":[{"name":"Aurora Primary Care Research Institute , Melbourne, Victoria 3130,","place":["Australia"]},{"name":"Department of General Practice, School of Primary and Allied Health Care, Monash University , Melbourne, Victoria 3168,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Aitken","sequence":"additional","affiliation":[{"name":"Gippsland Primary Health Network , Traralgon, Victoria 3844,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School, Monash University , Melbourne, Victoria 3199,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"issue":"2","key":"2024121301064550700_pnae071-B1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/pm\/pnaa322","article-title":"The prevalence of opioid analgesic use in people with chronic noncancer pain: systematic review and meta-analysis of observational studies","volume":"22","author":"Wertheimer","year":"2021","journal-title":"Pain Med"},{"issue":"4","key":"2024121301064550700_pnae071-B2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"4","key":"2024121301064550700_pnae071-B3","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","article-title":"Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study","volume":"7","author":"Ju","year":"2022","journal-title":"Lancet Public Health"},{"key":"2024121301064550700_pnae071-B4","author":"American Medical Association"},{"issue":"1","key":"2024121301064550700_pnae071-B5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.13792","article-title":"Prevalence and incidence of prescription opioid analgesic use in Australia","volume":"85","author":"Lalic","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2024121301064550700_pnae071-B6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/dar.13441","article-title":"Health harms of non-medical prescription opioid use: a systematic review","volume":"41","author":"Werb","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"2024121301064550700_pnae071-B7","author":"Penington Institute"},{"key":"2024121301064550700_pnae071-B8","author":"Australian Institute of Health and Welfare","year":"2020"},{"issue":"2","key":"2024121301064550700_pnae071-B9","doi-asserted-by":"publisher","first-page":"e2036687","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007\u20132018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2024121301064550700_pnae071-B10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/j.pain.0000000000002746","article-title":"Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines","volume":"164","author":"Hamilton","year":"2023","journal-title":"Pain"},{"issue":"9","key":"2024121301064550700_pnae071-B11","first-page":"21","article-title":"Opioid prescribing: what do the 2020 PBS changes mean for GPs","volume":"21","author":"Wilson","year":"2020","journal-title":"Med Today"},{"issue":"5","key":"2024121301064550700_pnae071-B12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.31128\/AJGP-04-20-5381","article-title":"General practitioner attitudes towards systems-level opioid prescribing interventions: a pooled secondary qualitative analysis","volume":"50","author":"Prathivadi","year":"2021","journal-title":"Aust J Gen Pract"},{"issue":"11","key":"2024121301064550700_pnae071-B13","doi-asserted-by":"publisher","first-page":"e1916271","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008\u20132017","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"suppl 3","key":"2024121301064550700_pnae071-B14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11606-020-06252-9","article-title":"Opioid discontinuation among patients receiving high-dose long-term opioid therapy in the Veterans Health Administration","volume":"35","author":"Minegishi","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2024121301064550700_pnae071-B15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40545-020-00271-x","article-title":"Prescription opioid dispensing in Canada: an update on recent developments to 2018","volume":"13","author":"Jones","year":"2020","journal-title":"J Pharm Policy Pract"},{"issue":"10","key":"2024121301064550700_pnae071-B16","doi-asserted-by":"publisher","first-page":"e1003270","DOI":"10.1371\/journal.pmed.1003270","article-title":"Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: a retrospective cohort study","volume":"17","author":"Jani","year":"2020","journal-title":"PLoS Med"},{"issue":"9","key":"2024121301064550700_pnae071-B17","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad167","article-title":"Predictors of persistent opioid use in non-cancer older adults: a retrospective cohort study","volume":"52","author":"Beyene","year":"2023","journal-title":"Age Ageing"},{"issue":"1","key":"2024121301064550700_pnae071-B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjhci-2019-100009","article-title":"Coding and classifying GP data: the POLAR project","volume":"26","author":"Pearce","year":"2019","journal-title":"BMJ Health Care Inform"},{"issue":"12","key":"2024121301064550700_pnae071-B19","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1016\/j.sapharm.2022.07.041","article-title":"Using primary care data to understand opioid prescribing, policy impacts and clinical outcomes: a protocol for the OPPICO study","volume":"18","author":"Cangadis-Douglass","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"2024121301064550700_pnae071-B20","doi-asserted-by":"publisher","first-page":"e067746","DOI":"10.1136\/bmjopen-2022-067746","article-title":"Cohort profile: using primary care data to understand Opioid Prescribing, Policy Impacts and Clinical Outcomes (OPPICO) in Victoria, Australia","volume":"13","author":"Nielsen","year":"2023","journal-title":"BMJ Open"},{"key":"2024121301064550700_pnae071-B21","doi-asserted-by":"publisher","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"2024121301064550700_pnae071-B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13722-022-00318-1","article-title":"Association between treatment setting and outcomes among Oregon Medicaid patients with opioid use disorder: a retrospective cohort study","volume":"17","author":"Hartung","year":"2022","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"2024121301064550700_pnae071-B23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/pm\/pnae002","article-title":"Trajectories of prescription opioid tapering in patients with chronic non-cancer pain: a retrospective cohort study, 2015\u20132020","volume":"25","author":"Jung","year":"2024","journal-title":"Pain Med"},{"issue":"10","key":"2024121301064550700_pnae071-B24","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1111\/bcp.14798","article-title":"Variations in long-term opioid therapy definitions: a systematic review of observational studies using routinely collected data (2000\u20132019)","volume":"87","author":"de Oliveira Costa","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"2024121301064550700_pnae071-B25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"2024121301064550700_pnae071-B26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/AJP.0000000000000948","article-title":"Inches, centimeters, and yards: overlooked definition choices inhibit interpretation of morphine equivalence","volume":"37","author":"Dasgupta","year":"2021","journal-title":"Clin J Pain"},{"issue":"6","key":"2024121301064550700_pnae071-B27","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/bcp.13556","article-title":"Predictors of persistent prescription opioid analgesic use among people without cancer in Australia","volume":"84","author":"Lalic","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2024121301064550700_pnae071-B28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/pds.4929","article-title":"Long-term opioid therapy definitions and predictors: a systematic review","volume":"29","author":"Karmali","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024121301064550700_pnae071-B29","author":"Australian Government Services Australia"},{"key":"2024121301064550700_pnae071-B30","author":"Australian Government Department of Health and Aged Care","year":"2023"},{"issue":"731","key":"2024121301064550700_pnae071-B31","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.3399\/BJGP.2022.0235","article-title":"Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study","volume":"73","author":"Tsang","year":"2023","journal-title":"Br J Gen Pract"},{"issue":"1","key":"2024121301064550700_pnae071-B32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12875-023-02134-1","article-title":"Identifying populations with chronic pain in primary care: developing an algorithm and logic rules applied to coded primary care diagnostic and medication data","volume":"24","author":"Hafezparast","year":"2023","journal-title":"BMC Prim Care"},{"issue":"9","key":"2024121301064550700_pnae071-B33","doi-asserted-by":"publisher","first-page":"e055528","DOI":"10.1136\/bmjopen-2021-055528","article-title":"Patterns of care for people presenting to Australian general practice with musculoskeletal complaints based on routinely collected data: protocol for an observational cohort study using the Population Level Analysis and Reporting (POLAR) database","volume":"11","author":"Haas","year":"2021","journal-title":"BMJ Open"},{"issue":"7","key":"2024121301064550700_pnae071-B34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/pds.4440","article-title":"Assumptions made when preparing drug exposure data for analysis have an impact on results: an unreported step in pharmacoepidemiology studies","volume":"27","author":"Pye","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2024121301064550700_pnae071-B35","doi-asserted-by":"publisher","first-page":"e045418","DOI":"10.1136\/bmjopen-2020-045418","article-title":"Trends in long-term opioid prescriptions for musculoskeletal conditions in Australian general practice: a national longitudinal study using MedicineInsight, 2012\u20132018","volume":"11","author":"Black-Tiong","year":"2021","journal-title":"BMJ Open"},{"key":"2024121301064550700_pnae071-B36","author":"Anekar","year":"2024"},{"key":"2024121301064550700_pnae071-B37","doi-asserted-by":"publisher","first-page":"108127","DOI":"10.1016\/j.drugalcdep.2020.108127","article-title":"Socioeconomic marginalization and opioid-related overdose: a systematic review","volume":"214","author":"van Draanen","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2024121301064550700_pnae071-B38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11096-020-01155-5","article-title":"Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years","volume":"43","author":"Adewumi","year":"2021","journal-title":"Int J Clin Pharm"},{"issue":"11","key":"2024121301064550700_pnae071-B39","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/pm\/pnw109","article-title":"Geographic variation in health service use and perceived access barriers for Australian adults with chronic non-cancer pain receiving opioid therapy","volume":"17","author":"Peacock","year":"2016","journal-title":"Pain Med"},{"issue":"6","key":"2024121301064550700_pnae071-B40","doi-asserted-by":"publisher","first-page":"e2216482","DOI":"10.1001\/jamanetworkopen.2022.16482","article-title":"Nonopioid treatments for chronic pain-integrating multimodal biopsychosocial approaches to pain management","volume":"5","author":"Eucker","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2024121301064550700_pnae071-B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40471-020-00225-6","article-title":"Pain and multimorbidity in late life","volume":"7","author":"Nakad","year":"2020","journal-title":"Curr Epidemiol Rep"},{"issue":"1","key":"2024121301064550700_pnae071-B42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","article-title":"Predicting risk of adverse drug reactions in older adults","volume":"7","author":"Lavan","year":"2016","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"2024121301064550700_pnae071-B43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamainternmed.2023.8154","article-title":"Age-related risk of serious fall events and opioid analgesic use","volume":"184","author":"Hopkins","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2024121301064550700_pnae071-B44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.12998\/wjcc.v5.i3.73","article-title":"Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults","volume":"5","author":"Guerriero","year":"2017","journal-title":"World J Clin Cases"},{"issue":"12","key":"2024121301064550700_pnae071-B45","doi-asserted-by":"publisher","first-page":"e2138453","DOI":"10.1001\/jamanetworkopen.2021.38453","article-title":"Substitution of nonpharmacologic therapy with opioid prescribing for pain during the COVID-19 pandemic","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2024121301064550700_pnae071-B46","author":"Australian Government Department of Health and Aged Care"},{"issue":"4","key":"2024121301064550700_pnae071-B47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/dar.13652","article-title":"Prescription drug monitoring programs in Australia: a call for a comprehensive evaluation","volume":"42","author":"Picco","year":"2023","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"2024121301064550700_pnae071-B48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/1753-6405.12030","article-title":"Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia","volume":"37","author":"Hollingworth","year":"2013","journal-title":"Aust N Z J Public Health"},{"key":"2024121301064550700_pnae071-B49","doi-asserted-by":"publisher","first-page":"564412","DOI":"10.3389\/fphar.2020.564412","article-title":"Prevalence of therapeutic use of opioids in chronic non-cancer pain patients and associated factors: a systematic review and meta-analysis","volume":"11","author":"De Sola","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"2024121301064550700_pnae071-B50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12874-021-01416-5","article-title":"A narrative review on the validity of electronic health record\u2013based research in epidemiology","volume":"21","author":"Gianfrancesco","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"2024121301064550700_pnae071-B51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M18-3079","article-title":"Graphical depiction of longitudinal study designs in health care databases","volume":"170","author":"Schneeweiss","year":"2019","journal-title":"Ann Intern Med"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnae071\/58851412\/pnae071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/25\/12\/748\/60811859\/pnae071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/25\/12\/748\/60811859\/pnae071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T01:06:55Z","timestamp":1734052015000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/25\/12\/748\/7728492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,8,6]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnae071","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,8,6]]}}}